COMMANDER (Completed)
Oral Rivaroxaban vs placebo for the prevention of CV events in chronic congestive HF subjects with significant obstructive CAD
- Medicine
- rivaroxaban
- Population
- ASCVD
- Phase
- III
- Starting year
- 2013
- More information
- ClinicalTrials.gov